NYSEAMERICAN:VNRX - VolitionRX Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.86 +0.13 (+7.51 %)
(As of 08/17/2018 04:00 PM ET)
Previous Close$1.86
Today's Range$1.72 - $1.86
52-Week Range$1.44 - $4.00
Volume90,793 shs
Average Volume111,970 shs
Market Capitalization$47.30 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.73
VolitionRX logoVolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.

Receive VNRX News and Ratings via Email

Sign-up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:VNRX
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity-139.57%
Return on Assets-98.81%

Miscellaneous

EmployeesN/A
Outstanding Shares30,030,000
Market Cap$47.30 million

VolitionRX (NYSEAMERICAN:VNRX) Frequently Asked Questions

What is VolitionRX's stock symbol?

VolitionRX trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "VNRX."

How were VolitionRX's earnings last quarter?

VolitionRX Ltd (NYSEAMERICAN:VNRX) issued its quarterly earnings results on Monday, August, 13th. The medical research company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.01. View VolitionRX's Earnings History.

When is VolitionRX's next earnings date?

VolitionRX is scheduled to release their next quarterly earnings announcement on Thursday, November, 8th 2018. View Earnings Estimates for VolitionRX.

What price target have analysts set for VNRX?

3 Wall Street analysts have issued 12-month price objectives for VolitionRX's shares. Their predictions range from $5.00 to $10.00. On average, they expect VolitionRX's stock price to reach $7.00 in the next year. This suggests a possible upside of 276.3% from the stock's current price. View Analyst Price Targets for VolitionRX.

What is the consensus analysts' recommendation for VolitionRX?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for VolitionRX in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for VolitionRX.

Who are some of VolitionRX's key competitors?

Some companies that are related to VolitionRX include DiaSorin (DIA), Spectral Medical (EDT), ANGLE (AGL), Premaitha Health (NIPT) and Proteome Sciences (PRM).

Who are VolitionRX's key executives?

VolitionRX's management team includes the folowing people:
  • Dr. Martin Charles Faulkes, Exec. Chairman (Age 74)
  • Mr. Cameron Reynolds, Founder, CEO, Pres & Director (Age 47)
  • Dr. Jacob Vincent Micallef Ph.D., MBA, Chief Scientific Officer (Age 62)
  • Dr. Jason Bradley Terrell, Chief Medical Officer & CEO of Volition America Inc. (Age 38)
  • Mr. Rodney Gerard Rootsaert LLB, Corp. Sec. (Age 47)

Has VolitionRX been receiving favorable news coverage?

Media coverage about VNRX stock has been trending somewhat positive recently, Accern reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. VolitionRX earned a media and rumor sentiment score of 0.11 on Accern's scale. They also gave news stories about the medical research company an impact score of 47.20 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View Recent Headlines for VolitionRX.

How do I buy shares of VolitionRX?

Shares of VNRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is VolitionRX's stock price today?

One share of VNRX stock can currently be purchased for approximately $1.86.

How big of a company is VolitionRX?

VolitionRX has a market capitalization of $47.30 million.


MarketBeat Community Rating for VolitionRX (NYSEAMERICAN VNRX)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  111 (Vote Outperform)
Underperform Votes:  59 (Vote Underperform)
Total Votes:  170
MarketBeat's community ratings are surveys of what our community members think about VolitionRX and other stocks. Vote "Outperform" if you believe VNRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VNRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.